Exhibit 10.2
Name: |
|
Number of Shares of Stock subject to Stock Option: |
|
Price Per Share: |
|
Date of Grant: |
|
Vesting Start Date: |
|
40674670_1
-2-
-3-
-4-
IN WITNESS WHEREOF, the Company has caused this Agreement to be executed by its duly authorized officer.
ULTRAGENYX PHARMACEUTICAL Inc.
By: ____________________________ Name: Emil Kakkis Title:Chief Executive Officer Dated:
Acknowledged and Agreed:
By_______________________
|